Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bladder cancer
Closed
Phase 3
This trial is looking at adding durvalumab to chemotherapy for people with bladder cancer that has grown into the muscle wall. This is invasive bladder cancer.
It is for people due to have surgery to remove their bladder. This surgery is called a cystectomy.
Recruitment start: 6 August 2019
Recruitment end: 30 July 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tom Powles
AstraZeneca
Last reviewed: 4 August 2021
CRUK internal database number: 16661